A safe and effective replacement valve for treating severe Tricuspid Regurgitation and preventing Right Ventricle dysfunction

Project Information

Trisol System

Grant agreement ID: 946589

DOI

10.3030/946589

Project closed

EC signature date 23 March 2020

Start date 1 February 2020

End date 31 January 2024

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost

€ 3 321 336,00

EU contribution

€ 2 324 935,20

Coordinated by

TRISOL MEDICAL LTD
Israel

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Websites, patent fillings, videos etc. (1)

Project Website

Trisol will set up an official project website, which will be regularly updated with news, clinical trial results, articles and material from participation at events.

Publications

Peer reviewed articles (1)

First-in-Human Percutaneous Transcatheter Tricuspid Valve Replacement With a Novel Valve

Author(s): Mordehay Vaturi, Hana Vaknin-Assa, Yaron Shapira, Leor Perl, Amos Levi, Arnon Koren, and Ran Kornowski
Published in: JACC Journal: Case Reports, 2021, ISSN 2666-0849
Publisher: JACC Journal: Case Reports
DOI: 10.1016/j.jaccas.2021.06.014